|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
DE69233528T2
(de)
|
1991-11-25 |
2006-03-16 |
Enzon, Inc. |
Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US7771951B2
(en)
|
2001-12-03 |
2010-08-10 |
Amgen Fremont Inc. |
Antibody categorization based on binding characteristics
|
|
US20030224000A1
(en)
*
|
2001-12-21 |
2003-12-04 |
Kokai-Kun John Fitzgerald |
Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
|
|
AU2007281433A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
EP3524619A1
(en)
*
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
KR101790354B1
(ko)
|
2009-05-11 |
2017-10-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 h3n2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
|
|
WO2011133886A2
(en)
|
2010-04-23 |
2011-10-27 |
Genentech, Inc. |
Production of heteromultimeric proteins
|
|
CN105490420B
(zh)
|
2010-06-25 |
2018-01-12 |
菲舍尔和佩克尔应用有限公司 |
马达转子、马达、包含该转子的电器和该转子的制造方法
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012109363A2
(en)
*
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
EP2731967B1
(en)
*
|
2011-07-14 |
2016-10-12 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
|
|
HUE044089T2
(hu)
|
2011-07-18 |
2019-09-30 |
Inst Res Biomedicine |
Neutralizáló anti-influenza A antitestek és alkalmazásaik
|
|
SI2766397T1
(sl)
|
2011-10-11 |
2018-09-28 |
F. Hoffmann-La Roche Ag |
Izboljšano sestavljanje bispecifičnih protiteles
|
|
WO2013081463A2
(en)
|
2011-12-02 |
2013-06-06 |
Aimm Therapeutics B.V. |
Influenza a virus specific antibodies
|
|
JP2019502715A
(ja)
|
2016-01-13 |
2019-01-31 |
メディミューン,エルエルシー |
A型インフルエンザを治療する方法
|
|
JP7332157B2
(ja)
|
2017-01-24 |
2023-08-23 |
ノースウェスタン ユニバーシティ |
アンジオテンシン変換酵素2(ace2)の活性な低分子量変異体
|
|
US20200095327A1
(en)
|
2017-02-08 |
2020-03-26 |
Dragonfly Therapeutics, Inc. |
Antibody heavy chain variable domains targeting the nkg2d receptor
|
|
WO2018187706A2
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
|
WO2018213097A1
(en)
|
2017-05-15 |
2018-11-22 |
University Of Rochester |
Broadly neutralizing anti-influenza monoclonal antibody and uses thereof
|
|
SG11202006379UA
(en)
|
2018-01-26 |
2020-07-29 |
Regeneron Pharma |
Human antibodies to influenza hemagglutinin
|
|
EP3758749A4
(en)
|
2018-03-02 |
2022-07-06 |
The University of Chicago |
METHOD AND COMPOSITION FOR NEUTRALIZING INFLUENZA
|
|
CA3096703A1
(en)
|
2018-05-03 |
2019-11-07 |
University Of Rochester |
Anti-influenza neuraminidase monoclonal antibodies and uses thereof
|
|
WO2020041540A1
(en)
|
2018-08-23 |
2020-02-27 |
Vanderbilt University |
Human monoclonal antibodies to a new universal influenza a hemagglutinin head domain epitope
|
|
CN111423507B
(zh)
|
2019-01-10 |
2022-04-15 |
中国科学院分子细胞科学卓越创新中心 |
广谱性中和流感病毒的全人抗体
|
|
JP2022519631A
(ja)
|
2019-02-12 |
2022-03-24 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
補体および標的抗原に結合する二重特異性抗体を使用するための組成物および方法
|
|
EP3946613A1
(en)
*
|
2019-03-25 |
2022-02-09 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
WO2020221450A1
(en)
|
2019-04-30 |
2020-11-05 |
Humabs Biomed Sa |
Antibodies and methods for treatment of influenza a infection
|
|
JP7634231B2
(ja)
|
2019-05-31 |
2025-02-21 |
ワシントン ユニバーシティ |
Pan-ノイラミニダーゼ阻害抗体
|
|
US20220298230A1
(en)
|
2019-06-11 |
2022-09-22 |
The Rockefeller University |
Antibodies and methods for treatment of viral infections
|
|
US11053724B2
(en)
|
2019-07-23 |
2021-07-06 |
Tony AWAD |
Device to assist in closing doors
|
|
US11448049B2
(en)
|
2019-09-05 |
2022-09-20 |
Flowco Production Solutions, LLC |
Gas assisted plunger lift control system and method
|
|
JP7611908B2
(ja)
|
2019-10-28 |
2025-01-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗血球凝集素抗体およびその使用方法
|
|
US20250263466A1
(en)
|
2020-02-03 |
2025-08-21 |
Vir Biotechnology, Inc. |
Antibodies against sars-cov-2 and methods of using the same
|
|
EP4100054A4
(en)
*
|
2020-02-07 |
2024-07-17 |
Washington University |
PROTECTIVE ANTIBODIES AGAINST INFLUENZA B
|
|
KR20220140568A
(ko)
|
2020-02-11 |
2022-10-18 |
벤더르빌트 유니버시티 |
중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 인간 단일클론 항체
|
|
CN115210248A
(zh)
|
2020-02-18 |
2022-10-18 |
北卡罗来纳大学查佩尔希尔分校 |
Aav衣壳-启动子相互作用和细胞选择性基因表达
|
|
PH12022552164A1
(en)
|
2020-02-19 |
2023-11-29 |
United Biomedical Inc |
Designer peptides and proteins for the detection, prevention and treatment of coronavirus disease, 2019 (covid-19)
|
|
CN111704665B
(zh)
|
2020-02-20 |
2022-04-01 |
南京农业大学 |
一种针对H3N2犬流感病毒的重组犬源化抗体scFv-Fc
|
|
HUE062777T2
(hu)
|
2020-02-26 |
2023-12-28 |
Vir Biotechnology Inc |
SARS-CoV-2 elleni antitestek
|
|
JP2023517234A
(ja)
|
2020-03-09 |
2023-04-24 |
アブセレラ バイオロジクス インコーポレイテッド |
抗コロナウイルス抗体および使用の方法
|
|
US11365239B2
(en)
|
2020-03-20 |
2022-06-21 |
Tsb Therapeutics (Beijing) Co., Ltd. |
Anti-SARS-COV-2 antibodies and uses thereof
|
|
CN111303280B
(zh)
|
2020-03-22 |
2022-01-07 |
中国人民解放军军事科学院军事医学研究院 |
高中和活性抗SARS-CoV-2全人源单克隆抗体及应用
|
|
EP4127174A4
(en)
|
2020-03-23 |
2024-05-01 |
Monash University |
ANTISENSE OLIGOMERS FOR THE TREATMENT OF DISEASES
|
|
WO2021195326A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
|
|
WO2021195418A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
|
|
US20230122364A1
(en)
|
2020-03-27 |
2023-04-20 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
|
|
CR20220552A
(es)
|
2020-04-02 |
2023-01-17 |
Regeneron Pharma |
Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno
|
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
|
TW202212354A
(zh)
|
2020-08-03 |
2022-04-01 |
美商健生生物科技公司 |
用於病毒治療劑中之多向生物運輸的材料及方法
|
|
WO2022075667A1
(ko)
|
2020-10-05 |
2022-04-14 |
한양대학교 산학협력단 |
안정화된 ace2 변이체, 이를 이용한 ace2-fc 융합단백질 및 covid-19 예방 또는 치료용 약학 조성물
|
|
WO2022082217A1
(en)
|
2020-10-16 |
2022-04-21 |
Eureka Therapeutics, Inc. |
Compositions for preventing or treating viral and other microbial infections
|